Efficacy of praziquantel in the treatment of Schistosoma haematobium infection among school-age children in rural communities of Abeokuta, Nigeria

Infectious Diseases of Poverty

Volumn 3, Issue 1, 2014, Pages

  Ojurongbe, Olusola ^a   Sina Agbaje, Olawunwi Risqat ^b   Busari, Abass ^c   Okorie, Patricia Nkem ^d   Ojurongbe, Taiwo Adetola ^e   Akindele, Akeem Abiodun ^a  

^a LADOKE AKINTOLA UNIVERSITY OF TECHNOLOGY   (Nigeria)

^b Olabisi Onabanjo University   (Nigeria)

^c Department of Medical Laboratory Services Olikoye Ransome Kuti Hospital   (Nigeria)

^d UNIVERSITY OF IBADAN   (Nigeria)

^e OSUN STATE UNIVERSITY   (Nigeria)

Author keywords

Drug efficacy; Nigeria; Praziquantel; School children; Urinary schistosomiasis

Indexed keywords

PRAZIQUANTEL;

ADOLESCENT; ARTICLE; CHILD; DRUG EFFICACY; FEMALE; FOLLOW UP; HEMATOCRIT; HUMAN; MAJOR CLINICAL STUDY; MALE; NIGERIA; OUTCOME ASSESSMENT; PARASITE IDENTIFICATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RURAL POPULATION; SCHISTOSOMIASIS HAEMATOBIA; SCHOOL CHILD; URINALYSIS;

EID: 84928810721     PISSN: 20955162     EISSN: 20499957     Source Type: Journal    
DOI: 10.1186/2049-9957-3-30     Document Type: Article

References (34)

1. Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Sachs SE, Sachs JD, Savioli L. Control of neglected tropical diseases. N Engl J Med 2007, 357:1018-1027. 10.1056/NEJMra064142, 17804846.
2. Hodges MH, Dada N, Warmsley A, Paye J, Bangura MM, Nyorkor E, Sonnie M, Zhang Y. Mass drug administration significantly reduces infection of Schistosoma mansoni and hookworm in school children in the national control program in Sierra Leone. BMC Infect Dis 2012, 12:16. 10.1186/1471-2334-12-16, 3282666, 22264258.
3. Ahmed AM, Abbas H, Mansour FA, Gasim GI, Adam I. Schistosoma haematobium infections among schoolchildren in central Sudan one year after treatment with praziquantel. Parasit Vectors 2012, 5:108. 10.1186/1756-3305-5-108, 3434009, 22676052.
4. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 2006, 6:411-425. 10.1016/S1473-3099(06)70521-7, 16790382.
5. Midzi N, Sangweme D, Zinyowera S, Mapingure MP, Brouwer KC, Kumar N, Mutapi F, Woelk G, Mduluza T. Efficacy and side effects of praziquantel treatment against Schistosoma haematobium infection among primary school children in Zimbabwe. Trans R Soc Trop Med Hyg 2008, 102:759-766. 10.1016/j.trstmh.2008.03.010, 18486169.
6. Feldmeier H, Krantz I, Poggensee G. Female genital schistosomiasis as a risk-factor for the transmission of HIV. Int J STD AIDS 1994, 5:368-372.
7. Seto EYW, Wong BK, Lu D, Zhong B. Human schistosomiasis resistance to praziquantel in China: should we be worried?. Am J Trop Med Hyg 2011, 85:74-82. 10.4269/ajtmh.2011.10-0542, 3122348, 21734129.
8. WHO Schistosomiasis and Soil Transmitted Helminth Infections - Preliminary Estimates of the Number of Children Treated with Albendazoleor Mebendazole 2006, 145-164. WHO.
9. McManus DP, Loukas A. Current Status of Vaccines for Schistosomiasis. Clin Microbiol Rev 2008, 21:225-242. 10.1128/CMR.00046-07, 2223839, 18202444.
10. Chai J-Y. Praziquantel Treatment in Trematode and Cestode Infections: An Update. Infect Chemother 2013, 45:32-43. 10.3947/ic.2013.45.1.32, 3780935, 24265948.
11. Barakat R, El Morshedy H. Efficacy of two praziquantel treatments among primary school children in an area of high Schistosoma mansoni endemicity, Nile Delta, Egypt. Parasitology 2011, 138:440-446. 10.1017/S003118201000154X, 21078223.
12. Tchuenté L-AT, Shaw DJ, Polla L, Cioli D, Vercruysse J. Efficacy of praziquantel against Schistosoma haematobium infection in children. Am J Trop Med Hyg 2004, 71:778-782.
13. Sabah AA, Fletcher C, Webbe G, Doenhoff MJ. Schistosoma mansoni: chemotherapy of infections of different ages. Exp Parasitol 1986, 61:294-303. 10.1016/0014-4894(86)90184-0, 3086114.
14. Sam-Wobo SO, Ekpo UF, Ameh IG, Osileye OT. Continued high endemicity of urinary schistosomiasis in Ogun State, Nigeria. Niger J Parasitol 2009, 30:48-52.
15. Ekpo UF, Alabi OM, Oluwole AS, Sam-Wobo SO. Schistosoma haematobium infections in preschool children from two rural communities in Ijebu East, south-western Nigeria. J Helminthol 2012, 86:323-328. 10.1017/S0022149X11000459, 22824258.
16. Tohon ZB, Mainassara HB, Garba A, Mahamane AE, Bosqué-Oliva E, Ibrahim M-L, Duchemin J-B, Chanteau S, Boisier P. Controlling schistosomiasis: significant decrease of anaemia prevalence one year after a single dose of praziquantel in Nigerian schoolchildren. PLoS Negl Trop Dis 2008, 2:e241. 10.1371/journal.pntd.0000241, 2386241, 18509472.
17. King CH, Olbrych SK, Soon M, Singer ME, Carter J, Colley DG. Utility of Repeated Praziquantel Dosing in the Treatment of Schistosomiasis in High-Risk Communities in Africa: A Systematic Review. PLoS Negl Trop Dis 2011, 5:e1321. 10.1371/journal.pntd.0001321, 3176745, 21949893.
18. Liu R, Dong H-F, Guo Y, Zhao Q-P, Jiang M-S. Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis. Parasit Vectors 2011, 4:201. 10.1186/1756-3305-4-201, 3207908, 22004571.
19. Akinwale O, Ajayi M, Akande D, Gyang P, Adeleke M, Adeneye A, Adebayo M, Dike A. Urinary Schistosomiasis around Oyan Reservoir, Nigeria: Twenty Years after the First Outbreak. Iran J Public Heal 2010, 39:92-95.
20. Houmsou RS, Kela SL, Suleiman MM. Performance of microhaematuria and proteinuria as measured by urine reagent strips in estimating intensity and prevalence of Schistosoma haematobium infection in Nigeria. Asian Pac J Trop Med 2011, 4:997-1000. 10.1016/S1995-7645(11)60233-2, 22118038.
21. WHO Assessing the Efficacy of Antihelminthic Drugs Against Schistosomiasis and Soil Transmitted Helminthiasis 2013, Geneva: World health Organization, WHO.
22. Stelma FF, Sall S, Daff B, Sow S, Niang M, Gryseels B. Oxamniquine cures Schistosoma mansoni infection in a focus in which cure rates with praziquantel are unusually low. J Infect Dis 1997, 176:304-307. 10.1086/517273, 9207389.
23. Guisse F, Polman K, Stelma FF, Mbaye A, Talla I, Niang M, Deelder AM, Ndir O, Gryseels B. Therapeutic evaluation of two different dose regimens of praziquantel in a recent Schistosoma mansoni focus in Northern Senegal. Am J Trop Med Hyg 1997, 56:511-514.
24. Liang YS, Coles GC, Doenhoff MJ. Short communication: Detection of praziquantel resistance in schistosomes. Trop Med Int Health 2000, 5:72-72. 10.1046/j.1365-3156.2000.00514.x, 10672208.
25. da Silva IM, Thiengo R, Conceição MJ, Rey L, Lenzi HL, Pereira Filho E, Ribeiro PC. Therapeutic failure of praziquantel in the treatment of Schistosoma haematobium infection in Brazilians returning from Africa. Memórias Inst Oswaldo Cruz 2005, 100:445-449.
26. Olds GR, King C, Hewlett J, Olveda R, Wu G, Ouma J, Peters P, McGarvey S, Odhiambo O, Koech D, Liu CY, Aligui G, Gachihi G, Kombe Y, Parraga I, Ramirez B, Whalen C, Horton RJ, Reeve P. Double-Blind Placebo-Controlled Study of Concurrent Administration of Albendazole and Praziquantel in Schoolchildren with Schistosomiasis and Geohelminths. J Infect Dis 1999, 179:996-1003. 10.1086/314686, 10068597.
27. Kabatereine NB, Kemijumbi J, Ouma JH, Sturrock RF, Butterworth AE, Madsen H, Ornbjerg N, Dunne DW, Vennnervald BJ. Efficacy and side effects of praziquantel treatment in a highly endemic Schistosoma mansoni focus at Lake Albert, Uganda. Trans R Soc Trop Med Hyg 2003, 97:599-603. 10.1016/S0035-9203(03)80044-5, 15307437.
28. Keiser J, Chollet J, Xiao S-H, Mei J-Y, Jiao P-Y, Utzinger J, Tanner M. Mefloquine-An Aminoalcohol with Promising Antischistosomal Properties in Mice. PLoS Negl Trop Dis 2009, 3:e350. 10.1371/journal.pntd.0000350, 2600813, 19125172.
29. Erko B, Degarege A, Tadesse K, Mathiwos A, Legesse M. Efficacy and side effects of praziquantel in the treatment of Schistosomiasis mansoni in schoolchildren in Shesha Kekele Elementary School, Wondo Genet, Southern Ethiopia. Asian Pac J Trop Biomed 2012, 2:235-239. 10.1016/S2221-1691(12)60049-5, 3609281, 23569905.
30. Ouf EA, Ojurongbe O, Akindele AA, Sina-Agbaje OR, Van Tong H, Adeyeba AO, Kremsner PG, Kun JFJ, Velavan T. Ficolin-2 levels and FCN2 genetic polymorphisms as a susceptibility factor in schistosomiasis. J Infect Dis 2012, 206:562-570. 10.1093/infdis/jis396, 22693230.
31. Ekpo UF, Laja-Deile A, Oluwole AS, Sam-Wobo SO, Mafiana CF. Urinary schistosomiasis among preschool children in a rural community near Abeokuta, Nigeria. Parasit Vectors 2010, 3:58. 10.1186/1756-3305-3-58, 2908585, 20602792.
32. King CH, Bertsch D. Meta-analysis of Urine Heme Dipstick Diagnosis of Schistosoma haematobium Infection. Including Low-Prevalence and Previously-Treated Populations. PLoS Negl Trop Dis 2013, 7:e2431. 10.1371/journal.pntd.0002431, 3772022, 24069486.
33. Sacko M, Magnussen P, Keita AD, Traoré MS, Landouré A, Doucouré A, Madsen H, Vennervald BJ. Impact of Schistosoma haematobium infection on urinary tract pathology, nutritional status and anaemia in school-aged children in two different endemic areas of the Niger River Basin, Mali. Acta Trop 2011, 120(Suppl 1):S142-150.
34. Utzinger J, Keiser J, Shuhua X, Tanner M, Singer BH. Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials. Antimicrob Agents Chemother 2003, 47:1487-1495. 10.1128/AAC.47.5.1487-1495.2003, 153321, 12709312.